when will retatrutide be approved Retatrutide, an experimental weight-loss drug, has not been by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. @adamyamaguchi Retatrutide for weight loss: Study
Description
doi: 10.1186/s40360-025-00977-1

Buie, who sees patients at both locations, spoke more about transitioning from GLP-1s to bariatric surgery

(2024, accessed 4 Apr 2025)

In the review business, its easy to give bias to smaller companies with a face behind them, but Hims overall feedback is representative of a decent, well-run public company

For GLP-1 clinics focused on long-term outcomes, RPM is what turns a prescription service into a care practice